Targeting BCR-ABL and JAK2 in Ph+ ALL

被引：3
|
作者：
Hantschel, Oliver [1 ]
机构：
[1] Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland
来源：
BLOOD | 2015年 / 125卷 / 09期
关键词：
INHIBITION; JAK2-STAT5; IMATINIB; CELLS;
D O I：
10.1182/blood-2014-12-617548
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1362 / 1363
页数：3
相关论文
共 50 条
  • [41] Jak2 is involved in c-Myc induction by Bcr-Abl.
    Hui, L
    Xie, SH
    Tong, S
    Arlinghaus, RB
    BLOOD, 2002, 100 (11) : 582A - 582A
  • [42] VARIABLE TRANSCRIPTION OF BCR-ABL BY PH+ CELLS ARISING FROM HEMATOPOIETIC PROGENITORS IN CHRONIC MYELOID-LEUKEMIA
    KEATING, A
    WANG, XH
    LARAYA, P
    BLOOD, 1994, 83 (07) : 1744 - 1749
  • [43] Detection of BCR-ABL kinase domain mutations in patients with CML and Ph plus ALL
    Zhang, T
    Nwachukwu, B
    Kamel-Raid, S
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (04): : 416 - 416
  • [44] IMPLICATIONS OF JAK2 MUTATION (V617F) ON THE EVOLUTION AND PROGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS BCR-ABL NEGATIVE
    Balea, M.
    Georgescu, D.
    Nicorescu, I.
    Ilea, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 606 - 606
  • [45] Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis
    Traverse-Glehen, A.
    Verney, A.
    Baseggio, L.
    Felman, P.
    Callet-Bauchu, E.
    Thieblemont, C.
    Ffrench, M.
    Magaud, J-P
    Coiffier, B.
    Berger, F.
    Salles, G.
    LEUKEMIA, 2007, 21 (08) : 1824 - 1826
  • [46] Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera
    Toogeh, Gholamreza
    Ferdowsi, Shirin
    Naadali, Fatemeh
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Shirkoohi, Reza
    Ghaffari, Seyed H.
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1555 - 1558
  • [47] Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera
    Gholamreza Toogeh
    Shirin Ferdowsi
    Fatemeh Naadali
    Kamran Alimoghaddam
    Ardeshir Ghavamzadeh
    Reza Shirkoohi
    Seyed H. Ghaffari
    Medical Oncology, 2011, 28 : 1555 - 1558
  • [48] Jak2 Regulates Bcr-Abl In CD34+Cells From Imatinib Mesylate-Resistant CML Patients
    Samanta, Ajoy K.
    Perazzona, Bastianella
    Chakraborty, Sandip N.
    Sun, Xiaoping
    Modi, Hardik
    Bhatia, Ravi
    Arlinghaus, Ralph
    BLOOD, 2010, 116 (21) : 522 - 522
  • [49] Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia
    de Mello Conchon, Monika Ribeiro
    Costa, Juliana Lima
    Yoshinaga Novaes, Mafalda Megumi
    Dorlhiac-Llacer, Pedro Enrique
    Fischer Chamone, Dalton de Alencar
    Bendit, Israel
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 243 - 245
  • [50] Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia
    Monika Ribeiro Mello de Conchon
    Juliana Lima Costa
    Mafalda Megumi Yoshinaga Novaes
    Pedro Enrique Dorlhiac-Llacer
    Dalton de Alencar Fischer Chamone
    Israel Bendit
    International Journal of Hematology, 2008, 88 : 243 - 245
12345